Zelira Therapeutics Ltd.ASX: ZLD

Zelira secures $1 Million At-the-Market Funding Facility

· Issued by Zelira Therapeutics Ltd.

Filed with ASX · · 4 pages · English

Summary by 6ix AI

Zelira Therapeutics Ltd. has secured an At-the-Market funding facility with Securities Vault to support its clinical programs and growth strategy. Zelira retains control over the timing and amount of capital issuances, minimizing dilution for shareholders. The agreement allows for the issuance of shares without shareholder approval, enhancing financial flexibility for the company.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zelira Therapeutics Ltd. on 6ix

In the deck

Earlier from Zelira Therapeutics

Later from Zelira Therapeutics

All Zelira Therapeutics news releases